Stock_Titan Posted - 2 weeks ago

$MXCT MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024 https://www.stocktitan.net/news/MXCT/max-cyte-to-report-first-quarter-2024-financial-results-on-may-7-p3o1b1hpbxki.html

Stock_Titan Posted - 3 weeks ago

$MXCT MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs) https://www.stocktitan.net/news/MXCT/max-cyte-signs-strategic-platform-license-with-be-biopharma-to-1kpolj7wlcnv.html

AnaChart Posted - 1 month ago

$MXCT https://anachart.com/wp-content/uploads/ana_temp/1710360123_soc-img.jpg

DonCorleone77 Posted - 1 month ago

$MXCT MaxCyte affirms FY24 guidance The company states: "Management is reiterating 2024 revenue guidance for core business revenue and SPL Program-related revenue. Management expects full year 2024 core business revenue to be flat to 5% growth compared to 2023, and SPL Program-related revenue is expected to be approximately $3 million. Our outlook for the full year does not include SPL Program-related revenue from Vertex/CRISPR's CASGEVYTM and reflects a difficult year-over-year comparison from a client milestone recognized in 2023 that was initially expected in 2024. Management expects to end 2024 with $175 million in total cash, cash equivalents and investments."

DonCorleone77 Posted - 1 month ago

$MXCT MaxCyte reports Q4 EPS (5c), consensus (7c) Reports Q4 revenue $15.7M, consensus $13.1M. "In 2023, we navigated a challenging operating environment in our industry, that included increased capital conservatism and pipeline portfolio reevaluation among our customers. Our team adapted well to the changing environment last year, and I am confident in our ability to execute across the business this year," said Maher Masoud, President and CEO of MaxCyte. "We are pleased with our accomplishments and progress in 2023, which included supporting the recent FDA approval of CASGEVYTM by our client, Vertex Pharmaceuticals. MaxCyte signed five new SPLs in 2023 and we have seen continued momentum with three additional SPLs signed in January 2024. Our pipeline of potential clients remains robust, and we look forward to further expanding our portfolio of SPLs in 2024. The opportunity in front of us in the cell therapy industry continues to strengthen, and we will focus on executing in 2024...

epsguid Posted - 1 month ago

$MXCT reported a loss of $0.05, consensus was ($0.10) via @eWhispers #epsbeat http://eps.sh/d/mxct

Stock_Titan Posted - 1 month ago

$MXCT MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance https://www.stocktitan.net/news/MXCT/max-cyte-reports-fourth-quarter-and-full-year-2023-financial-results-o69ow3ke7eq9.html

DonCorleone77 Posted - 1 month ago

$MXCT MaxCyte sees FY24 core revenue flat to up 5%, consensus $42.14M Management expects to end 2024 with $175M in total cash, cash equivalents and investments. "We are looking forward to continuing to execute across our business and provide best in class support to our customers in 2024 and the years to come. This year, MaxCyte has already signed three SPLs in which our cell and gene therapy clients will use our Flow Electroporation(R) technology and ExPERT(TM) platform to further their pre-clinical and clinical programs," said Maher Masoud, president and CEO at MaxCyte. "As we continue to expand our SPL portfolio this year, we remain confident in our ability to support our current and prospective clients as new waves of next-generation cell therapies come to market."

DonCorleone77 Posted - 1 month ago

$MXCT MaxCyte backs FY23 core revenue view $41.1M-$41.3M, consensus $39.77M The company said, "SPL Program-related revenue is expected to be approximately $11.4 million, compared to $4.6 million for fiscal year 2022."

Stock_Titan Posted - 1 month ago

$MXCT MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results https://www.stocktitan.net/news/MXCT/max-cyte-initiates-full-year-2024-guidance-and-reaffirms-2023-0kz32b6izc2w.html

adorejohnny Posted - 2 months ago

$MXCT i'm back in this, i missed this stock <3

Ninja_Tradez Posted - 2 months ago

📢 $MXCT - MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences https://newsfilter.io/a/4700800a966540f0004283f42360fcdc

Stock_Titan Posted - 2 months ago

$MXCT MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/MXCT/max-cyte-to-report-fourth-quarter-and-full-year-2023-financial-lrl8cb5gqa9m.html

insiderbuyingselling Posted - 01/30/24

$MXCT new insider selling: 5000 shares. http://insiderbuyingselling.com/?t=MXCT

Last10K Posted - 3 months ago

$MXCT just filed with the SEC a Event for Officers and a Financial Exhibit https://last10k.com/sec-filings/MXCT/0001558370-24-000593.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=MXCT

Steadfastly Posted - 3 months ago

$MXCT https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240123:nGNX20LsDg&default-theme=true

TAFox Posted - 3 months ago

$MXCT it’s crazy how few are watching this!

StockAutomatePro Posted - 3 months ago

$MXCT The chart is showing an upward trajectory for the stock. We alerted the BUY signal at $4.65 and we were able to close this one with profit at $5.375 😎

StockAutomatePro Posted - 3 months ago

$MXCT Looks like the stock is in for a good stretch according to the chart. We alerted the BUY signal at $4.62 and we were able to close this one with profit at $5.35 💯

StockAutomatePro Posted - 3 months ago

$MXCT The chart is indicating an upward trajectory for the stock price We alerted the BUY signal at $4.71 and we were able to close this one with profit at $5.29 🎲

StockAutomatePro Posted - 3 months ago

$MXCT Stock may be headed for a surge according to the chart. We alerted the BUY signal at $4.63 and we were able to close this one with profit at $5.22 🥳

trditup11 Posted - 3 months ago

$MXCT $CRSP $VRTX all worked together to develop this drug $mxct is so undervalued here

trditup11 Posted - 3 months ago

$MXCT $CRSP $VRTX https://finance.yahoo.com/news/vertex-announces-approval-first-crispr-174200871.html

trditup11 Posted - 3 months ago

$MXCT time to take out the 52 week high...

HunterEasty Posted - 3 months ago

$CLRB $CYCN $MXCT Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts. Highly recommended! It's free joining<> https://live-alerts-stock-trades.blogspot.com/2024/01/shares-extend-winning-streak.html

HudsonMorgans Posted - 3 months ago

$JWEL $MXCT $ACET Started trading over 4 months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts. Highly recommended! It's free joining<> https://live-alerts-stock-trades.blogspot.com/2024/01/shares-extend-winning-streak.html

TAFox Posted - 3 months ago

$MXCT beautiful!

EarningsInsider Posted - 3 months ago

$MXCT updates FY 2023 guidance to EPS and revenue guidance to $41.1 million-$41.3 million. www.marketbeat.com/stocks/NASDAQ/MXCT/earnings/

EarningsInsider Posted - 3 months ago

$MXCT updates Q4 2023 guidance to EPS and revenue guidance to $15.5 million-$15.7 million. www.marketbeat.com/stocks/NASDAQ/MXCT/earnings/

TAFox Posted - 3 months ago

$MXCT let’s freaking go!